A carregar...
Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome
OBJECTIVE: Neonatal abstinence syndrome (NAS)—a clinical entity of infants from in utero exposure to psychoactive xenobiotic and buprenorphine—has been successfully used to treat NAS. However, nothing is known about the pharmacokinetics (PK) of buprenorphine in neonates with NAS. To our knowledge, t...
Na minha lista:
| Publicado no: | Pharmacotherapy |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5119858/ https://ncbi.nlm.nih.gov/pubmed/26172282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1610 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|